As shown in Fig. 7D, F and G, the expression of DNMT3A increased significantly when EZH2 was knocked down; CCL22 and CCR4 were downregulated in tumor tissues, and EMT-related protein expression also changed consistent with in vitro results. This evidence concerns the gene DNMT3A and neoplasm.